Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression

Biological Psychiatry

Volumn 81, Issue 8, 2017, Pages 645-653

  Francis, T Chase ^a   Lobo, Mary Kay ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Deep brain stimulation; Excitatory synaptic transmission; Medium spiny neuron; Social defeat; Stress; Striatum

Indexed keywords

DEPRESSION; DORSAL STRIATUM; HUMAN; MEDIUM SPINY NEURON; NERVE CELL PLASTICITY; NERVE CELL STIMULATION; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; REVIEW; SYNAPTIC TRANSMISSION; ANIMAL; BRAIN; C57BL MOUSE; COMPLICATION; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; MALE; MENTAL STRESS; MOUSE; NERVE CELL; NERVE TRACT; PATHOPHYSIOLOGY; PHYSIOLOGY; SOCIAL BEHAVIOR;

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR;

ANIMALS; BRAIN; DEPRESSION; DEPRESSIVE DISORDER; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; NEURAL PATHWAYS; NEURONS; NUCLEUS ACCUMBENS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SOCIAL BEHAVIOR; STRESS, PSYCHOLOGICAL;

EID: 85006857204     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2016.09.007     Document Type: Review

References (97)

1. 1 Gaynes, B.N., Warden, D., Trivedi, M.H., Wisniewski, S.R., Fava, M., Rush, A.J., What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv 60 (2009), 1439–1445.
2. 2 Mayberg, H.S., Lozano, A.M., Voon, V., McNeely, H.E., Seminowicz, D., Hamani, C., et al. Deep brain stimulation for treatment-resistant depression. Neuron 45 (2005), 651–660.
3. 3 Mayberg, H.S., Targeted electrode-based modulation of neural circuits for depression. J Clin Invest 119 (2009), 717–725.
4. 4 Cusin, C., Dougherty, D.D., Somatic therapies for treatment-resistant depression: ECT, TMS, VNS, DBS. Biol Mood Anxiety Disord, 2, 2012 14-5380-2-14.
5. 5 Bewernick, B.H., Kayser, S., Sturm, V., Schlaepfer, T.E., Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: Evidence for sustained efficacy. Neuropsychopharmacology 37 (2012), 1975–1985.
6. 6 Schlaepfer, T.E., Bewernick, B.H., Neuromodulation for treatment resistant depression: State of the art and recommendations for clinical and scientific conduct. Brain Topogr 27 (2014), 12–19.
7. 7 Bewernick, B., Schlaepfer, T.E., Update on neuromodulation for treatment-resistant depression. F1000Res 4:10.12688/f1000research.6633.1, 2015 eCollection 2015.
8. 8 Schlaepfer, T.E., Cohen, M.X., Frick, C., Kosel, M., Brodesser, D., Axmacher, N., et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 33 (2008), 368–377.
9. 9 George, M.S., Wassermann, E.M., Williams, W.A., Callahan, A., Ketter, T.A., Basser, P., et al. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 6 (1995), 1853–1856.
10. 10 Williams, Z.M., Good vibrations with deep brain stimulation. Nat Neurosci 18 (2015), 618–619.
11. 11 Pittenger, C., Duman, R.S., Stress, depression, and neuroplasticity: A convergence of mechanisms. Neuropsychopharmacology 33 (2008), 88–109.
12. 12 Pariante, C.M., Lightman, S.L., The HPA axis in major depression: Classical theories and new developments. Trends Neurosci 31 (2008), 464–468.
13. 13 Drevets, W.C., Price, J.L., Furey, M.L., Brain structural and functional abnormalities in mood disorders: Implications for neurocircuitry models of depression. Brain Struct Funct 213 (2008), 93–118.
14. 14 Floresco, S.B., The nucleus accumbens: An interface between cognition, emotion, and action. Annu Rev Psychol 66 (2015), 25–52.
15. 15 Voorn, P., Vanderschuren, L.J., Groenewegen, H.J., Robbins, T.W., Pennartz, C.M., Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci 27 (2004), 468–474.
16. 16 Gerfen, C.R., Engber, T.M., Mahan, L.C., Susel, Z., Chase, T.N., Monsma, F.J. Jr, et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250 (1990), 1429–1432.
17. 17 Lobo, M.K., Karsten, S.L., Gray, M., Geschwind, D.H., Yang, X.W., FACS-array profiling of striatal projection neuron subtypes in juvenile and adult mouse brains. Nat Neurosci 9 (2006), 443–452.
18. 18 Heiman, M., Schaefer, A., Gong, S., Peterson, J.D., Day, M., Ramsey, K.E., et al. A translational profiling approach for the molecular characterization of CNS cell types. Cell 135 (2008), 738–748.
19. 19 Koob, G.F., Swerdlow, N.R., The functional output of the mesolimbic dopamine system. Ann N Y Acad Sci 537 (1988), 216–227.
20. 20 Smith, R.J., Lobo, M.K., Spencer, S., Kalivas, P.W., Cocaine-induced adaptations in D1 and D2 accumbens projection neurons (a dichotomy not necessarily synonymous with direct and indirect pathways). Curr Opin Neurobiol 23 (2013), 546–552.
21. 21 Kupchik, Y.M., Brown, R.M., Heinsbroek, J.A., Lobo, M.K., Schwartz, D.J., Kalivas, P.W., Coding the direct/indirect pathways by D1 and D2 receptors is not valid for accumbens projections. Nat Neurosci 18 (2015), 1230–1232.
22. 22 McEwen, B.S., Bowles, N.P., Gray, J.D., Hill, M.N., Hunter, R.G., Karatsoreos, I.N., et al. Mechanisms of stress in the brain. Nat Neurosci 18 (2015), 1353–1363.
23. 23 Krishnan, V., Nestler, E.J., The molecular neurobiology of depression. Nature 455 (2008), 894–902.
24. 24 Kravitz, A.V., Tye, L.D., Kreitzer, A.C., Distinct roles for direct and indirect pathway striatal neurons in reinforcement. Nat Neurosci 15 (2012), 816–818.
25. 25 Kravitz, A.V., Freeze, B.S., Parker, P.R., Kay, K., Thwin, M.T., Deisseroth, K., et al. Regulation of Parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 466 (2010), 622–626.
26. 26 Lobo, M.K., Covington, H.E. 3rd, Chaudhury, D., Friedman, A.K., Sun, H., Damez-Werno, D., et al. Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 330 (2010), 385–390.
27. 27 Ferguson, S.M., Phillips, P.E., Roth, B.L., Wess, J., Neumaier, J.F., Direct-pathway striatal neurons regulate the retention of decision-making strategies. J Neurosci 33 (2013), 11668–11676.
28. 28 Tai, L.H., Lee, A.M., Benavidez, N., Bonci, A., Wilbrecht, L., Transient stimulation of distinct subpopulations of striatal neurons mimics changes in action value. Nat Neurosci 15 (2012), 1281–1289.
29. 29 Bock, R., Shin, J.H., Kaplan, A.R., Dobi, A., Markey, E., Kramer, P.F., et al. Strengthening the accumbal indirect pathway promotes resilience to compulsive cocaine use. Nat Neurosci 16 (2013), 632–638.
30. 30 Chandra, R., Lenz, J.D., Gancarz, A.M., Chaudhury, D., Schroeder, G.L., Han, M.H., et al. Optogenetic inhibition of D1R containing nucleus accumbens neurons alters cocaine-mediated regulation of Tiam1. Front Mol Neurosci, 6, 2013, 13.
31. 31 Chandra, R., Francis, T.C., Konkalmatt, P., Amgalan, A., Gancarz, A.M., Dietz, D.M., et al. Opposing role for Egr3 in nucleus accumbens cell subtypes in cocaine action. J Neurosci 35 (2015), 7927–7937.
32. 32 Sanacora, G., Treccani, G., Popoli, M., Towards a glutamate hypothesis of depression: An emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 62 (2012), 63–77.
33. 33 Thompson, S.M., Kallarackal, A.J., Kvarta, M.D., Van Dyke, A.M., LeGates, T.A., Cai, X., An excitatory synapse hypothesis of depression. Trends Neurosci 38 (2015), 279–294.
34. 34 Drevets, W.C., Videen, T.O., Price, J.L., Preskorn, S.H., Carmichael, S.T., Raichle, M.E., A functional anatomical study of unipolar depression. J Neurosci 12 (1992), 3628–3641.
35. 35 Anacker, C., Scholz, J., O'Donnell, K.J., Allemang-Grand, R., Diorio, J., Bagot, R.C., et al. Neuroanatomic differences associated with stress susceptibility and resilience. Biol Psychiatry 79 (2016), 840–849.
36. 36 Lim, B.K., Huang, K.W., Grueter, B.A., Rothwell, P.E., Malenka, R.C., Anhedonia requires MC4R-mediated synaptic adaptations in nucleus accumbens. Nature 487 (2012), 183–189.
37. 37 Krishnan, V., Han, M.H., Graham, D.L., Berton, O., Renthal, W., Russo, S.J., et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131 (2007), 391–404.
38. 38 Berton, O., McClung, C.A., Dileone, R.J., Krishnan, V., Renthal, W., Russo, S.J., et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311 (2006), 864–868.
39. 39 Christoffel, D.J., Golden, S.A., Dumitriu, D., Robison, A.J., Janssen, W.G., Ahn, H.F., et al. IkappaB kinase regulates social defeat stress-induced synaptic and behavioral plasticity. J Neurosci 31 (2011), 314–321.
40. 40 Khibnik, L.A., Beaumont, M., Doyle, M., Heshmati, M., Slesinger, P.A., Nestler, E.J., et al. Stress and cocaine trigger divergent and cell type-specific regulation of synaptic transmission at single spines in nucleus accumbens. Biol Psychiatry 79 (2016), 898–905.
41. 41 Francis, T.C., Chandra, R., Friend, D.M., Finkel, E., Dayrit, G., Miranda, J., et al. Nucleus accumbens medium spiny neuron subtypes mediate depression-related outcomes to social defeat stress. Biol Psychiatry 77 (2015), 212–222.
42. 42 Holtzheimer, P.E. 3rd, Mayberg, H.S., Deep brain stimulation for treatment-resistant depression. Am J Psychiatry 167 (2010), 1437–1444.
43. 43 Delaloye, S., Holtzheimer, P.E., Deep brain stimulation in the treatment of depression. Dialogues Clin Neurosci 16 (2014), 83–91.
44. 44 Covington, H.E. 3rd, Lobo, M.K., Maze, I., Vialou, V., Hyman, J.M., Zaman, S., et al. Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex. J Neurosci 30 (2010), 16082–16090.
45. 45 Vialou, V., Bagot, R.C., Cahill, M.E., Ferguson, D., Robison, A.J., Dietz, D.M., et al. Prefrontal cortical circuit for depression- and anxiety-related behaviors mediated by cholecystokinin: Role of DeltaFosB. J Neurosci 34 (2014), 3878–3887.
46. 46 Levkovitz, Y., Harel, E.V., Roth, Y., Braw, Y., Most, D., Katz, L.N., et al. Deep transcranial magnetic stimulation over the prefrontal cortex: Evaluation of antidepressant and cognitive effects in depressive patients. Brain Stimul 2 (2009), 188–200.
47. 47 Bagot, R.C., Parise, E.M., Pena, C.J., Zhang, H.X., Maze, I., Chaudhury, D., et al. Ventral hippocampal afferents to the nucleus accumbens regulate susceptibility to depression. Nat Commun, 6, 2015, 7062.
48. 48 Christoffel, D.J., Golden, S.A., Walsh, J.J., Guise, K.G., Heshmati, M., Friedman, A.K., et al. Excitatory transmission at thalamo-striatal synapses mediates susceptibility to social stress. Nat Neurosci 18 (2015), 962–964.
49. 49 Britt, J.P., Benaliouad, F., McDevitt, R.A., Stuber, G.D., Wise, R.A., Bonci, A., Synaptic and behavioral profile of multiple glutamatergic inputs to the nucleus accumbens. Neuron 76 (2012), 790–803.
50. 50 Shen, W., Flajolet, M., Greengard, P., Surmeier, D.J., Dichotomous dopaminergic control of striatal synaptic plasticity. Science 321 (2008), 848–851.
51. 51 Dang, Y.H., Ma, X.C., Zhang, J.C., Ren, Q., Wu, J., Gao, C.G., et al. Targeting of NMDA receptors in the treatment of major depression. Curr Pharm Des 20 (2014), 5151–5159.
52. 52 Joffe, M.E., Vitter, S.R., Grueter, B.A., GluN1 deletions in D1- and A2A-expressing cell types reveal distinct modes of behavioral regulation. Neuropharmacology 112(Pt A) (2016), 172–180.
53. 53 Bean, B.P., The action potential in mammalian central neurons. Nat Rev Neurosci 8 (2007), 451–465.
54. 54 Friedman, A.K., Walsh, J.J., Juarez, B., Ku, S.M., Chaudhury, D., Wang, J., et al. Enhancing depression mechanisms in midbrain dopamine neurons achieves homeostatic resilience. Science 344 (2014), 313–319.
55. 55 Yizhar, O., Fenno, L.E., Davidson, T.J., Mogri, M., Deisseroth, K., Optogenetics in neural systems. Neuron 71 (2011), 9–34.
56. 56 Meeks, J.P., Jiang, X., Mennerick, S., Action potential fidelity during normal and epileptiform activity in paired soma-axon recordings from rat hippocampus. J Physiol 566 (2005), 425–441.
57. 57 Taverna, S., Ilijic, E., Surmeier, D.J., Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease. J Neurosci 28 (2008), 5504–5512.
58. 58 Dobbs, L.K., Kaplan, A.R., Lemos, J.C., Matsui, A., Rubinstein, M., Alvarez, V.A., Dopamine regulation of lateral inhibition between striatal neurons gates the stimulant actions of cocaine. Neuron 90 (2016), 1100–1113.
59. 59 Covington, H.E. 3rd, Vialou, V., Nestler, E.J., From synapse to nucleus: Novel targets for treating depression. Neuropharmacology 58 (2010), 683–693.
60. 60 Dunlop, B.W., Nemeroff, C.B., The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry 64 (2007), 327–337.
61. 61 Willner, P., Muscat, R., Papp, M., Chronic mild stress-induced anhedonia: A realistic animal model of depression. Neurosci Biobehav Rev 16 (1992), 525–534.
62. 62 Cabib, S., Giardino, L., Calza, L., Zanni, M., Mele, A., Puglisi-Allegra, S., Stress promotes major changes in dopamine receptor densities within the mesoaccumbens and nigrostriatal systems. Neuroscience 84 (1998), 193–200.
63. 63 Plattner, F., Hayashi, K., Hernandez, A., Benavides, D.R., Tassin, T.C., Tan, C., et al. The role of ventral striatal cAMP signaling in stress-induced behaviors. Nat Neurosci 18 (2015), 1094–1100.
64. 64 Barik, J., Marti, F., Morel, C., Fernandez, S.P., Lanteri, C., Godeheu, G., et al. Chronic stress triggers social aversion via glucocorticoid receptor in dopaminoceptive neurons. Science 339 (2013), 332–335.
65. 65 Cao, J.L., Covington, H.E. 3rd, Friedman, A.K., Wilkinson, M.B., Walsh, J.J., Cooper, D.C., et al. Mesolimbic dopamine neurons in the brain reward circuit mediate susceptibility to social defeat and antidepressant action. J Neurosci 30 (2010), 16453–16458.
66. 66 Chaudhury, D., Walsh, J.J., Friedman, A.K., Juarez, B., Ku, S.M., Koo, J.W., et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature 493 (2013), 532–536.
67. 67 Koo, J.W., Labonte, B., Engmann, O., Calipari, E.S., Juarez, B., Lorsch, Z., et al. Essential role of mesolimbic brain-derived neurotrophic factor in chronic social stress-induced depressive behaviors. Biol Psychiatry 80 (2015), 469–478.
68. 68 Walsh, J.J., Friedman, A.K., Sun, H., Heller, E.A., Ku, S.M., Juarez, B., et al. Stress and CRF gate neural activation of BDNF in the mesolimbic reward pathway. Nat Neurosci 17 (2014), 27–29.
69. 69 Tye, K.M., Mirzabekov, J.J., Warden, M.R., Ferenczi, E.A., Tsai, H.C., Finkelstein, J., et al. Dopamine neurons modulate neural encoding and expression of depression-related behaviour. Nature 493 (2013), 537–541.
70. 70 Koo, J.W., Mazei-Robison, M.S., Chaudhury, D., Juarez, B., LaPlant, Q., Ferguson, D., et al. BDNF is a negative modulator of morphine action. Science 338 (2012), 124–128.
71. 71 Knoll, A.T., Carlezon, W.A. Jr, Dynorphin, stress, and depression. Brain Res 1314 (2010), 56–73.
72. 72 Lutz, P.E., Kieffer, B.L., Opioid receptors: Distinct roles in mood disorders. Trends Neurosci 36 (2013), 195–206.
73. 73 Shirayama, Y., Chaki, S., Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents. Curr Neuropharmacol 4 (2006), 277–291.
74. 74 Mague, S.D., Pliakas, A.M., Todtenkopf, M.S., Tomasiewicz, H.C., Zhang, Y., Stevens, W.C. Jr, et al. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 305 (2003), 323–330.
75. 75 Newton, S.S., Thome, J., Wallace, T.L., Shirayama, Y., Schlesinger, L., Sakai, N., et al. Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J Neurosci 22 (2002), 10883–10890.
76. 76 Chefer, V.I., Backman, C.M., Gigante, E.D., Shippenberg, T.S., Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion. Neuropsychopharmacology 38 (2013), 2623–2631.
77. 77 Al-Hasani, R., McCall, J.G., Shin, G., Gomez, A.M., Schmitz, G.P., Bernardi, J.M., et al. Distinct subpopulations of nucleus accumbens dynorphin neurons drive aversion and reward. Neuron 87 (2015), 1063–1077.
78. 78 Poulin, J.F., Laforest, S., Drolet, G., Enkephalin downregulation in the nucleus accumbens underlies chronic stress-induced anhedonia. Stress 17 (2014), 88–96.
79. 79 De Felipe, M.C., De Ceballos, M.L., Gil, C., Fuentes, J.A., Chronic antidepressant treatment increases enkephalin levels in n. accumbens and striatum of the rat. Eur J Pharmacol 112 (1985), 119–122.
80. 80 Broom, D.C., Jutkiewicz, E.M., Folk, J.E., Traynor, J.R., Rice, K.C., Woods, J.H., Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats. Neuropsychopharmacology 26 (2002), 744–755.
81. 81 Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H.W., Simonin, F., et al. Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25 (2000), 195–200.
82. 82 Vialou, V., Robison, A.J., Laplant, Q.C., Covington, H.E. 3rd, Dietz, D.M., Ohnishi, Y.N., et al. DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nat Neurosci 13 (2010), 745–752.
83. 83 Kelz, M.B., Chen, J., Carlezon, W.A. Jr, Whisler, K., Gilden, L., Beckmann, A.M., et al. Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature 401 (1999), 272–276.
84. 84 Lobo, M.K., Zaman, S., Damez-Werno, D.M., Koo, J.W., Bagot, R.C., DiNieri, J.A., et al. DeltaFosB induction in striatal medium spiny neuron subtypes in response to chronic pharmacological, emotional, and optogenetic stimuli. J Neurosci 33 (2013), 18381–18395.
85. 85 Grueter, B.A., Robison, A.J., Neve, R.L., Nestler, E.J., Malenka, R.C., FosB differentially modulates nucleus accumbens direct and indirect pathway function. Proc Natl Acad Sci U S A 110 (2013), 1923–1928.
86. 86 Golden, S.A., Christoffel, D.J., Heshmati, M., Hodes, G.E., Magida, J., Davis, K., et al. Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression. Nat Med 19 (2013), 337–344.
87. 87 Lisman, J., Schulman, H., Cline, H., The molecular basis of CaMKII function in synaptic and behavioural memory. Nat Rev Neurosci 3 (2002), 175–190.
88. 88 Robison, A.J., Vialou, V., Sun, H.S., Labonte, B., Golden, S.A., Dias, C., et al. Fluoxetine epigenetically alters the CaMKIIalpha promoter in nucleus accumbens to regulate DeltaFosB binding and antidepressant effects. Neuropsychopharmacology 39 (2014), 1178–1186.
89. 89 Pi, H.J., Otmakhov, N., Lemelin, D., De Koninck, P., Lisman, J., Autonomous CaMKII can promote either long-term potentiation or long-term depression, depending on the state of T305/T306 phosphorylation. J Neurosci 30 (2010), 8704–8709.
90. 90 Klug, J.R., Mathur, B.N., Kash, T.L., Wang, H.D., Matthews, R.T., Robison, A.J., et al. Genetic inhibition of CaMKII in dorsal striatal medium spiny neurons reduces functional excitatory synapses and enhances intrinsic excitability. PLoS One, 7, 2012, e45323.
91. 91 Wilkinson, M.B., Dias, C., Magida, J., Mazei-Robison, M., Lobo, M., Kennedy, P., et al. A novel role of the WNT-dishevelled-GSK3beta signaling cascade in the mouse nucleus accumbens in a social defeat model of depression. J Neurosci 31 (2011), 9084–9092.
92. 92 Dias, C., Feng, J., Sun, H., Shao, N.Y., Mazei-Robison, M.S., Damez-Werno, D., et al. β-catenin mediates stress resilience through Dicer1/microRNA regulation. Nature 516 (2014), 51–55.
93. 93 Kessler, R.C., Epidemiology of women and depression. J Affect Disord 74 (2003), 5–13.
94. 94 Hodes, G.E., Pfau, M.L., Purushothaman, I., Ahn, H.F., Golden, S.A., Christoffel, D.J., et al. Sex differences in nucleus accumbens transcriptome profiles associated with susceptibility versus resilience to subchronic variable stress. J Neurosci 35 (2015), 16362–16376.
95. 95 Javadifar, T.S., Sahraei, H., Ketabi, M.A., Nasehi, M., Zarrindast, M.R., Transient inactivation of the nucleus accumbens (NAc) shell prominently ameliorates responses to acute stress in female rats. Brain Res 1649(Pt A) (2016), 1–8.
96. 96 LaPlant, Q., Chakravarty, S., Vialou, V., Mukherjee, S., Koo, J.W., Kalahasti, G., et al. Role of nuclear factor kappaB in ovarian hormone-mediated stress hypersensitivity in female mice. Biol Psychiatry 65 (2009), 874–880.
97. 97 Campi, K.L., Greenberg, G.D., Kapoor, A., Ziegler, T.E., Trainor, B.C., Sex differences in effects of dopamine D1 receptors on social withdrawal. Neuropharmacology 77 (2014), 208–216.